Full-Time

Director – Patient Access

Cah

Confirmed live in the last 24 hours

Neurocrine Biosciences

Neurocrine Biosciences

1,001-5,000 employees

Biotechnology
Healthcare

Compensation Overview

$188.5k - $272.9kAnnually

+ Bonus + Equity Incentive Program

Senior, Expert

Remote in USA

Home office setup in South Dakota.

Category
Public Health
Biology & Biotech
Requirements
  • BS/BA degree in related field and 15+ years of life science experience of which 5+ years needs to be in specialty pharmacy/market access and five years’ leading a team within commercial. Specialty product experience, rare disease required. Endocrinology experience preferred OR
  • Master's or MBA degree preferred and 13+ years of related experience OR
  • PhD and 10+ years of related experience and Extensive previous managerial experiences also required
  • Previous experience in other life science roles in highly preferred
  • Recognized as an internal thought leader with extensive technical and business expertise within a strategic organization
  • Applies in-depth knowledge of own function, business / commercial / scientific expertise to solve critical issues successfully and innovatively
  • Evaluates key business / scientific challenges and completes complex, ambiguous initiatives having cross-functional impact
  • Ability to coach, lead and motivate a field team
  • Strong leadership and organizational skills. demonstrated project and people management capabilities
  • Excellent interpersonal and cross functional team success. proven ability to build productive relationships and teams internally and externally
  • Excellent oral and written communication skills
  • Strong understanding of the prescription adjudication process
  • Ability to communicate payer coverage criteria and prior authorization processes
  • Possesses good understanding of current issues within the marketplace, pharmaceutical industry, and national health care system
  • Strong understanding of specialty pharmacies, managed care, pharmacy benefit managers and government payers, and their impact on product access
  • Excellent working knowledge of patient support programs, including reimbursement support, financial assistance, and adherence programs
  • Certified Prior Authorization Specialist
Responsibilities
  • Leads, motivates and develops an effective and compliant Regional Patient Access Manager (RPAM) field-based team and patient access strategy for rare disease.
  • Cooperates and coordinates cross-functionally with field sales, national accounts, patient services, network specialty pharmacy, and home office colleagues within market access and other related functional departments, such as commercial analytics and operations, to support patient access with targeted payers.
  • Responsible for providing patient access support services and education at the regional level, including interactions with HCPs, office support staff, helping to maximize patient access to Company products.
  • Subject matter expert on regional and national payer coverage policies and processes.
  • Provides training and education on payer-specific coverage policies and documentation requirements, appeals processes for specific payers and patient financial assistance support programs, including Company copay assistance programs and patient assistance program.
  • Identifies and communicates payer issues with market access leadership and the national account directors (NAD) team.
  • Communicates regularly to management, both corporate and field-based, the opportunities and challenges related to patient access, the Hub and Specialty Pharmacy network.
  • Presents insight into payer coverage policies and processes at internal business reviews to leadership and at national/regional sales meetings.
  • Works to ensure a diverse and inclusive environment free from all forms of discrimination and harassment.
  • Other duties as assigned.
Neurocrine Biosciences

Neurocrine Biosciences

View

Company Stage

IPO

Total Funding

N/A

Headquarters

San Diego, California

Founded

N/A

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Positive Phase 2 data for NBI-1117568 in schizophrenia and the launch of INGREZZA SPRINKLE highlight Neurocrine's innovative pipeline and commitment to addressing unmet medical needs.
  • The FDA's acceptance of crinecerfont's New Drug Applications with Priority Review could lead to a significant market breakthrough if approved.
  • Recent investments and executive appointments suggest strong confidence in the company's future growth and strategic direction.

What critics are saying

  • The pharmaceutical industry is highly competitive, and Neurocrine must continuously innovate to maintain its market position.
  • Regulatory hurdles, such as FDA rejections, could delay product launches and impact financial performance.

What makes Neurocrine Biosciences unique

  • Neurocrine Biosciences is pioneering in the treatment of congenital adrenal hyperplasia (CAH) with crinecerfont, a first-in-class therapy that hasn't seen innovation in 70 years.
  • The company offers unique formulations like INGREZZA SPRINKLE, addressing specific patient needs such as dysphagia, which sets them apart in the pharmaceutical landscape.
  • Their focus on rare and serious endocrine disorders, combined with successful clinical trials, positions them as a leader in niche therapeutic areas.

Help us improve and share your feedback! Did you find this helpful?